Functional Characterization of WTX in Renal Development
Functional Characterization of WTX in Renal Development
批准号:
7674515
负责人:
Miguel Nicolas Rivera
金额:
$13.8万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2012-08-31
关键词:
AccountingAdultAffectAwardBiochemicalBiological ModelsCell Culture TechniquesCell LineCell ProliferationCellsChildhoodChildhood Renal NeoplasmCollaborationsDefectDevelopmentDown-RegulationEmbryoEpitheliumFrasier SyndromesGenesGenitourinary systemIn VitroInsulin-Like Growth Factor IIKidneyKidney DiseasesKidney NeoplasmsKnockout MiceKnowledgeLaboratoriesLentivirus VectorMalignant NeoplasmsModelingMusMutationNephroblastomaNorth AmericaOrganogenesisPatternPhenotypePhysiologicalPrimary NeoplasmPropertyProteinsPublic Health Applications ResearchRenal carcinomaResearch PersonnelResolutionRoleSpecimenTP53 geneTumor Suppressor GenesTumor Suppressor ProteinsUp-RegulationWT1 geneWound Healingauthoritybeta catenincomparative genomic hybridizationkidney cellnephrogenesisnovelpodocyteprogramsresearch studytissue culturetumortumorigenesis
中文摘要
描述(由申请人提供):
肾母细胞瘤是一种多能性肿瘤,起源于胚胎肾前体细胞,是最常见的儿童肾脏肿瘤,也是第四常见的儿童恶性肿瘤。第一个在肾母细胞瘤中失活的基因是肿瘤抑制因子WT 1,其功能特征强调了这些肿瘤与肾脏发育之间的联系。WT 1是小鼠肾脏发育所必需的,也是WAGR、Denys-Drash和Frasier综合征中泌尿生殖系统缺陷的原因。然而,WT 1仅在5-10%的散发性肾母细胞瘤中失活。已描述了β-连环蛋白、胰岛素样生长因子2(IGF 2)和p53的改变,但没有已知的特定遗传缺陷导致大多数病例。该KO 8奖的候选人Miguel里维拉博士已经鉴定并克隆了一种新的肿瘤抑制基因WTX,该基因在30%的散发性肾母细胞瘤病例中失活。值得注意的是,WTX以高度调节的模式表达,在肾脏发育过程中部分重叠WT 1。因此,与WT 1类似,预期WTX是肾母细胞瘤发生和肾发育中的关键基因。该候选人现在建议建立在这些初步结果的基础上,并表征WTX在肾脏发育中的功能特性。目的1:研究WTX的生化特性。慢病毒载体将用于以接近生理水平表达WTX并确定与其他蛋白质的关联。目的2:明确WTX在肾脏发育组织培养模型中的作用。将在早期肾发育(RSTEM细胞-多能肾细胞系)和完全分化的肾上皮细胞(小鼠足细胞系)的细胞培养模型中评估WTX上调和下调的功能后果。目的3:表征小鼠肾脏中条件性WTX失活的后果。与Nabeel Bardeesy博士的实验室合作正在产生一种条件性WTX敲除小鼠。作为这项合作的一部分,候选人将分析这种小鼠在肾脏发育中的表型。预计,通过进一步了解早期肾脏发育,该项目将在儿科和成人肾脏疾病,肾组织修复和肾癌方面具有公共卫生应用。
英文摘要
DESCRIPTION (provided by applicant):
Wilms tumor is a pluripotent tumor which arises from embryonic renal precursors and is the most common pediatric kidney tumor and the fourth most common childhood malignancy. The first gene shown to be inactivated in Wilms tumor was the tumor suppressor WT1 and its functional characterization has emphasized the connection between these tumors and renal development. WT1 is essential for kidney development in mice and it is also responsible for genitourinary defects in the WAGR, Denys-Drash and Frasier syndromes. WT1, however, is inactivated in only 5-10% of sporadic Wilms' tumors. Alterations in beta-catenin, insulin-like growth factor 2 (IGF2) and p53 have been described but there are no known specific genetic defects that account for the majority of cases. The candidate for this KO8 award, Dr. Miguel Rivera, has identified and cloned a novel tumor suppressor gene, WTX, which is inactivated in 30% of sporadic Wilms tumor cases. Remarkably, WTX is expressed in a highly regulated pattern that partially overlaps WT1 during kidney development. Thus, by analogy to WT1, WTX is expected be a critical gene in both Wilms tumorigenesis and kidney development. The candidate now proposes to build on these initial results and characterize the functional properties of WTX in renal development. Aim 1: To characterize the biochemical properties of WTX. Lentiviral vectors will be used to express WTX at near physiologic levels and to determine associations with other proteins. Aim 2: To define the role of WTX in tissue culture models of renal development. The functional consequences of WTX upregulation and downregulation will be assessed in cell culture models of early renal development (RSTEM cells - a pluripotent renal cell line ) and fully differentiated kidney epithelia (a mouse podocyte cell line). Aim 3: To characterize the consequences of conditional WTX inactivation in the mouse kidney. A conditional WTX knockout mouse is being generated in collaboration with the laboratory of Dr. Nabeel Bardeesy. As part of this collaboration, the candidate will analyze the phenotype of this mouse in kidney development. It is anticipated that, by furthering our knowledge of early kidney development, this project will have public health applications in pediatric and adult kidney disease, kidney tissue repair and kidney cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Toxicity Induced by EWS/FLI1 Overdose in Ewing Sarcoma
-
批准号:10719095
-
项目类别:
-
资助金额:$73.31万
-
财政年份:2023
-
负责人:Miguel Nicolas Rivera
-
依托单位:
Functional Characterization of WTX in Renal Development
-
批准号:8141353
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2007
-
负责人:Miguel Nicolas Rivera
-
依托单位:
Functional Characterization of WTX in Renal Development
-
批准号:7500170
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2007
-
负责人:Miguel Nicolas Rivera
-
依托单位:
Functional Characterization of WTX in Renal Development
-
批准号:7361683
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2007
-
负责人:Miguel Nicolas Rivera
-
依托单位:
Functional Characterization of WTX in Renal Development
-
批准号:7924889
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2007
-
负责人:Miguel Nicolas Rivera
-
依托单位:
海外基金